Since BMI and tumor glucose metabolism are both linked to breast cancer subtypes and patient outcome, the combination of these two prognosticators may have added prognostic value to the tumor subtype according to estrogen receptor, progesterone receptor, and HER2 status. Here, ESR1 is linked to neoplasm.